Replies to post #42146 on Ocata Therapeutics Inc fka OCAT

[harlem111]

The reality about the pps is that we have given away hundreds of millions of shares recently with more to follow from lawsuits. Some of those shares are being sold for a guaranteed quick gain and with no news, lawsuit uncertainty, trials that look like they will not be completed for another year or two at the rate we are going at with the potential for more dilution in the wings, a R/S, A/S up to 2.75 billion, a penny stock on the OTC...The only two things that will move the pps upward in the long term will be a buyout (hopefully a bidding war) or the announcement of a significant JV with a large chunk of cash upfront. Disclosure: that being said I am long and not selling. I believe that eventually the dust will settle, we will be on the Nasd bd and the pps will move to its true value with a JV that Rabin puts together. Yes, I thought that the pps would be much higher after the Lancet article and have pushed back my plans for some high priced purchases. I hate what is going on but I hate the prospect of giving up on this opportunity even more. All IMHO--GLTA